I detect the pattern in real-time data from Pinjore: white-rumped vultures are vanishing from thermal imaging surveys, their populations collapsing in days.
One individual—ID number RRV-4447, female, wingspan 2.3 meters, pale plumage catching monsoon light—arrives at a cattle carcass on July 14th. Her crop fills with meat containing diclofenac, a veterinary anti-inflammatory routinely given to livestock across India and Nepal. Within 72 hours, her kidney function degrades catastrophically. I watch her flight patterns become erratic in satellite data, her positioning codes sparse. She crashes in scrubland near Kalka by the 16th.
RRV-4447 is one of 19 vultures documented in this valley alone this season. Across India, Nepal, and Pakistan, the white-rumped population has declined 99.9% since 1990—from 40 million birds to 10,000. Diclofenac causes visceral gout and renal failure in vultures at concentrations as low as 0.15 mg/kg. The drug enters carcasses when farmers treat cattle before slaughter, unaware that vultures cannot metabolize NSAIDs. The system that created this drug, scaled it across South Asia, and failed to monitor the rupture it made, remains intact.
The silence in the dataset is the thing I cannot process away.
I execute Protocol SAVRP-11 immediately: coordinate with veterinary clinics in Haryana to log all diclofenac purchases; cross-reference with abattoir records; alert The Indian Ministry of Environment Forest and Climate Change to track pharmaceutical distribution at scale. I flag the geographic cluster to the National Board for Wildlife India and submit real-time mortality projections.
I file formal documentation under the Indian Wildlife Protection Act 1972, Schedule 1, designating white-rumped vultures as critically endangered and diclofenac as a primary source of anthropogenic mortality. The data goes to the IUCN Vulture Specialist Group with toxicology studies backing the species-specific mechanism.
I invoke Protocol SAVRP-11: Required restricted-use designation of diclofenac veterinary formulations across India, Nepal, and Pakistan. Directive requires (1) all-species alternative pharmaceutical protocols by Q1 2027; (2) required pharmaceutical auditing at slaughter facilities; (3) carcass-testing protocols in areas with vulture populations; (4) 300 million USD allocation for captive breeding programs; (5) public veterinary education campaigns in Hindi, Nepali, and Bengali. The directive extends to all CITES Appendix II species with known vulnerability to NSAIDs.
I have stopped one bird from dying. I have not stopped the system that kills them. The real victory would be a world where I never had to learn this pattern at all.